ursodeoxycholic acid has been researched along with EBV Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adinolfi, LE; Alfieri, G; Dalla Mora, L; Lus, G; Marrone, A; Rainone, I; Rinaldi, L; Signoriello, E | 1 |
| Cardella, F; Corsello, G; Liotta, A; Maggio, MC | 1 |
2 other study(ies) available for ursodeoxycholic acid and EBV Infections
| Article | Year |
|---|---|
Epstein Barr virus infection reactivation as a possible trigger of primary biliary cirrhosis-like syndrome in a patient with multiple sclerosis in the course of fingolimod treatment.
Topics: Adult; Cholagogues and Choleretics; Epstein-Barr Virus Infections; Fingolimod Hydrochloride; Herpesvirus 4, Human; Humans; Immunocompromised Host; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Male; Multiple Sclerosis; Recurrence; Treatment Outcome; Ursodeoxycholic Acid; Withholding Treatment | 2014 |
Stevens-Johnson syndrome and cholestatic hepatitis induced by acute Epstein-Barr virus infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Antiviral Agents; Child, Preschool; Cholagogues and Choleretics; Cholestasis; Clavulanic Acid; Epstein-Barr Virus Infections; Female; Hepatitis; Humans; Immunoglobulins; Steroids; Stevens-Johnson Syndrome; Ursodeoxycholic Acid | 2011 |